GRIDIRON PUBLIC AFFAIRS, LLC

Registrant on federal lobbying filings · filed 2026 to 2026

$20,000 Income reported

3 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (401110604), not by name.

Clients 3

AGIOS PHARMACEUTICALS $10,000 2 filings
BEAM THERAPEUTICS $10,000 2 filings
BEREN THERAPEUTICS $0 2 filings

Reported by year 1 year

2026 $20,000 6 filings

Issues lobbied 1

Health Issues 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 3
SENATE 3

Recent filings 6 total

Q2

BEREN THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · posted Jul 16, 2026

View → Q2

BEAM THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 16, 2026

View → Q2

AGIOS PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 16, 2026

View → RR

BEREN THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · posted May 26, 2026

View → RR

BEAM THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · posted May 26, 2026

View → RR

AGIOS PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2026 · posted May 26, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.